Archivos de Medicina is a prominent open-access journal published by the Universidad de Manizales, Facultad de Medicina, dedicated to advancing the field of medical sciences. With an ISSN of 1657-320X and an E-ISSN of 2339-3874, this journal has been a key resource for researchers and healthcare professionals since its inception in 2012, facilitating the broad dissemination of high-quality, peer-reviewed research. Its commitment to open access ensures that critical medical research is available to all, promoting collaboration and innovation across various disciplines. Archivos de Medicina aims to publish original articles, reviews, and case studies that contribute to the understanding and improvement of health systems, medical practice, and public health. By fostering an international dialogue among scholars and practitioners, the journal plays a vital role in shaping evidence-based medicine, making it an invaluable resource for anyone dedicated to advancing healthcare knowledge and practice.

The International Journal of Cancer Management is a distinguished publication dedicated to advancing knowledge and research in the fields of cancer management, oncology, pharmacology, and radiology. Published by BRIEFLAND in the Netherlands, this journal serves as a vital resource for researchers, healthcare professionals, and students interested in the latest developments in cancer care and treatment strategies. With an ISSN of 2538-4422 and an E-ISSN of 2538-497X, the journal features a range of peer-reviewed articles that cover diverse aspects of cancer management, reflecting its commitment to high-quality, impactful research. The journal ranks in the Q4 category for Cancer Research and Oncology and Q3 for both Pharmacology and Surgery in 2023, signifying its growing influence in the scientific community. Through its open access format, the International Journal of Cancer Management ensures that critical research findings are accessible to all, promoting collaboration and innovation in the battle against cancer. Researchers looking to share their findings or learn more about current trends will find this journal an invaluable addition to their professional toolkit.

Annals of African Medicine is a distinguished academic journal dedicated to the exploration and dissemination of significant research within the field of medicine, particularly focused on the African context. Published by Wolters Kluwer Medknow Publications in India, this journal has been a vital platform for scholars since its inception in 2005, with a commitment to improving healthcare practices and outcomes across the continent. While it currently holds a Q4 ranking in the broader field of Medicine (miscellaneous) according to the 2023 category quartiles, it has the potential to foster valuable insights that address unique medical challenges facing African populations. The journal's ISSN is 1596-3519, and it is also available under the E-ISSN 0975-5764. Accessible to a diverse audience of researchers, professionals, and students, the Annals of African Medicine not only serves as an academic archive but also encourages discussions and initiatives aimed at advancing health-related knowledge and practices in Africa.

ANNALS OF MEDICINE, published by Taylor & Francis Ltd, stands as a leading journal in the field of medical research, holding a prestigious Q1 ranking within the miscellaneous medicine category as of 2023. With a focus on disseminating high-quality, peer-reviewed research, the journal provides a vital platform for scholars, clinicians, and policy-makers to share innovative findings that advance the understanding and practice of medicine. Established in 1961, ANNALS OF MEDICINE has continuously evolved, promoting interdisciplinary approaches and fostering collaboration among researchers across various medical specialties. Its impressive Scopus rank of #103 out of 636, representing the top 83rd percentile in general medicine, underscores its influence and importance in the medical community. Although it does not offer Open Access options, the journal remains committed to maintaining rigorous academic standards, making it an essential resource for anyone dedicated to improving healthcare outcomes through scholarly research.

Vojnosanitetski Pregled is a distinguished open-access journal published by the Military Medical Academy in Serbia, with a commitment to disseminating high-quality research since 2002. Operating under the ISSN 0042-8450 and E-ISSN 2406-0720, it serves as a vital platform for scholars and practitioners in the fields of Medicine and Pharmacology, specifically addressing the unique challenges faced within military and veterans' health care. With a publication history spanning from 1949 to 2024, the journal has established itself as a reputable source of knowledge, currently holding a Q4 category ranking in both Medicine (miscellaneous) and Pharmacology (medical) as of 2023, and a Scopus rank of 240 out of 272, placing it in the 11th percentile. Vojnosanitetski Pregled aims to foster innovative research, facilitate collaboration among professionals, and contribute significantly to the ongoing development of military medical practices and policies. By prioritizing accessibility and engagement, this journal is an invaluable resource for researchers, healthcare professionals, and students eager to explore the intersection of military medicine and pharmacology.

JNCI-Journal of the National Cancer Institute, published by Oxford University Press Inc. in the United Kingdom, is a premier journal dedicated to advancing the field of cancer research and oncology. With a distinguished history dating back to 1940, this journal has consistently maintained a strong reputation within the academic community, achieving a remarkable Q1 ranking in both Cancer Research and Oncology as of 2023. Researchers and practitioners rely on the JNCI for original research articles, review papers, and cutting-edge findings that impact clinical practices and therapeutic strategies. Although it does not currently offer open access, the journal remains a vital resource for academicians and healthcare professionals seeking to enhance their understanding of cancer mechanisms and treatment innovations. Its rigorous peer-review process ensures the publication of high-quality, credible research that meets the evolving challenges of cancer treatment and prevention through to 2024.

Clinical and Experimental Medicine is a leading journal published by Springer-Verlag Italia SRL, dedicated to advancing the understanding of the intricate relationships between biomedical research and clinical applications. Since its inception in 2001, the journal has garnered an esteemed reputation, achieving Q1 quartile rankings in 2023 in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Medicine (miscellaneous), establishing itself as a key resource for researchers and practitioners alike. With an impactful contribution reflected in its Scopus rankings, particularly a #81/221 rank in the General Biochemistry, Genetics and Molecular Biology category, Clinical and Experimental Medicine serves as a rich platform for peer-reviewed articles that bridge theory and practice across diverse medical disciplines. The journal embraces Open Access options, broadening the accessibility of groundbreaking research to a global audience, thereby fostering collaboration and innovation. Located in Milan, Italy, it continually endeavors to enrich knowledge and share valuable insights essential for the advancement of health sciences.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE is a premier peer-reviewed academic journal published by WILEY-HINDAWI, dedicated to advancing the field of clinical medicine. With an ISSN of 1368-5031 and E-ISSN 1742-1241, this open access journal has been providing a platform for insightful research since its inception in 1997 and continues to contribute significantly to the medical community, as indicated by its Q2 ranking in Medicine (miscellaneous) for 2023 and its position in the top 15% of Scopus-ranked journals. The journal invites innovative studies, systematic reviews, and clinical trials, making it a critical resource for healthcare professionals, researchers, and students seeking to stay updated on the latest clinical practices. Based in the United Kingdom at Adam House, 3rd Fl, 1 Fitzroy Sq, London W1T 5HE, this journal supports open accessibility, enhancing the dissemination of vital research findings across the globe. Join the growing community of scholars who contribute to and benefit from this influential publication as it continues to shape the future of clinical practice.

Chronic Obstructive Pulmonary Diseases - Journal of the COPD Foundation, published by the esteemed COPD Foundation, serves as a vital platform for advancing research in the field of pulmonary and respiratory medicine. With an ISSN of 2372-952X, this journal emphasizes the exploration and dissemination of knowledge related to chronic obstructive pulmonary disease (COPD) while addressing broader topics in respiratory health. Recognized within the Q2 category of the 2023 *Scopus* rankings and positioned at the 47th percentile in its field, the journal showcases innovative studies, clinical insights, and evidence-based practices crucial for professionals, researchers, and students alike. Although operating as a traditional publication, it seeks to provide immediate access to groundbreaking research on the prevention and management of COPD, facilitating improved patient outcomes. As it continues to expand its influence since its convergence in 2018, this journal is dedicated to bridging gaps in pulmonary medicine, making it an indispensable resource for the global respiratory health community.

Rawal Medical Journal, published by the Pakistan Medical Association, is a prominent academic resource committed to disseminating innovative research in the fields of medicine and nursing. With an ISSN of 0303-5212, this journal serves as a key platform for scholars, practitioners, and students in Pakistan and beyond, contributing to the evolving discourse in healthcare. Although it is currently categorized in the Q4 quartile for both Medicine (miscellaneous) and Nursing (miscellaneous), the journal remains an essential publication for those seeking to enhance their understanding of emerging medical trends and professional practices. Covering research from 2008 to 2024, it aims to foster a collaborative environment for practitioner-oriented and clinical investigations, despite its preliminary ranking in both categories. The journal does not offer Open Access, which invites readers to obtain institutional access or purchase articles directly, ensuring that high-quality research remains accessible to those committed to advancing their knowledge in these vital fields. With its headquarters located at PMA House, Aga Khan III Rd, Karachi, Pakistan, the Rawal Medical Journal is particularly well-situated to address both local and global health challenges.